2021 ATA Guidelines for Management of Patients with Anaplastic Thyroid Cancer (ATC) Guidelines – Endorsement Response
The 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer has recently been accepted for publication in the Thyroid journal. This is being shared with you because the ATA is committed to providing and updating information in thyroidology and collaborations that influence thyroid health or thyroid-related investigation. An expert task force of the American Thyroid Association was led by Co-chairs Electron Kebebew, MD, Stanford University, Stanford, CA and Keith Bible, MD, Mayo Clinic, Rochester, MN.
To endorse the guidelines – we ask that two of your organization’s authorized signers complete the form below.
Should you have any questions or additional feedback on these guidelines please include in the comments / feedback section below or you may contact Sharleene Cano, ATA’s Director of Publications and Membership by email: scano@thyroid.org.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.